Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07232043 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs

Name: ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs — clinical trial record (NCT07232043)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ACTIVATE

StatusRecruiting

PhaseNot applicable

SponsorDana-Farber Cancer Institute

Started2026-07-20

View on ClinicalTrials.gov ↗

Amendment history

2026-09-17

Recruitment opened

2026-04-27

Study Status v1

Start date2026-02→2026-06

2025-11-14

Original filing

Dana-Farber Cancer Institute

287 trials monitored

See 33 trials at risk

This study aims to develop and evaluate ACTIVATE, an AI-driven tool for clinical trial information and viability assessment using electronic health records (EHRs). The project will leverage retrospective and prospective EHR data to build and validate algorithms that identify potentially eligible participants for clinical trials and facilitate trial matching.

Trial Details

NCT Number	NCT07232043
Lead Sponsor	Dana-Farber Cancer Institute Collaborators: National Cancer Institute (NCI)
Conditions	Cancer
Enrollment	70,000 participants
Start Date	2026-07-20
Primary Completion	2030-06-30 (estimated)
Study Completion	2030-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-09-16